- News
Anthropic Opens Tiered AI Access for Life Sciences
Anthropic gives verified life sciences researchers tiered Claude access for drug discovery, with a governance model other regulated industries will follow.
- News
Claude Discovers Enzyme System Humans Missed for Decades
Anthropic's Claude autonomously found a new CRISPR-like enzyme system in bacteriophage DNA — in 21 hours. Here's what it means for AI-powered work.
- News
Claude Designs Protein Binders for 14 of 15 Targets
Anthropic's Claude ran an end-to-end protein design campaign, hitting 22-35% success versus the 10-15% industry norm for autonomous scientific agents.
- News
Cognizant Is Now Anthropic's Top-Tier Claude Partner
30,000 Cognizant staff are Claude-certified. Production results: 40% faster contract review for pharma, 8 hours/week saved per insurance underwriter.
- News
Anthropic Bets on Pharma with New AI for Science Vertical
Anthropic's June 30 AI for Science briefing and Bristol Myers Squibb's 30,000-seat Claude rollout show enterprise AI moving into regulated science.
- News
OpenAI Launches GPT-Rosalind for Life Sciences
OpenAI's GPT-Rosalind targets drug discovery and genomics research, beating human experts on RNA prediction tasks. What it means for data-driven industries.
AI Pulse, the daily read
EDNA Learn
Start learning
For teams
Training & Advisory
Advisory & leadership
Build & train
Omni Command Centre
Resources
AI Pulse